S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSEAMERICAN:MYO

Myomo (MYO) Stock Price, News & Analysis

$3.27
-0.23 (-6.57%)
(As of 03/28/2024 ET)
Today's Range
$3.23
$3.50
50-Day Range
N/A
52-Week Range
$0.37
$5.58
Volume
92,358 shs
Average Volume
418,581 shs
Market Capitalization
$93.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50

Myomo MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
98.8% Upside
$6.50 Price Target
Short Interest
Healthy
2.81% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.31mentions of Myomo in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$175,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.18) to ($0.05) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.64 out of 5 stars

MYO stock logo

About Myomo Stock (NYSEAMERICAN:MYO)

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

MYO Stock Price History

MYO Stock News Headlines

[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript
Myomo Q4 2023 Earnings Preview
MYO Mar 2024 7.500 call
Myomo Earnings Preview
Here's what Wall Street expects from Myomo's earnings
Myomo Stock Rises 6% After 4Q Preliminary Results
See More Headlines
Receive MYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Myomo and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:MYO
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.50
High Stock Price Target
$6.50
Low Stock Price Target
$6.50
Potential Upside/Downside
+98.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-8,150,000.00
Pretax Margin
-41.54%

Debt

Sales & Book Value

Annual Sales
$19.24 million
Book Value
$0.34 per share

Miscellaneous

Free Float
27,575,000
Market Cap
$93.16 million
Optionable
Not Optionable
Beta
1.51
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Paul R. Gudonis (Age 69)
    Chairman, President & CEO
    Comp: $358.79k
  • Mr. David A. Henry (Age 63)
    Chief Financial Officer
    Comp: $273.1k
  • Dr. Harry Kovelman M.D. (Age 65)
    Chief Medical Officer
    Comp: $277.58k
  • Colin Anderson
    Global Director of Operations
  • Mr. Joseph Chicoskie
    Director of Marketing
  • Ms. Galina Shtivelman
    Senior Director of Human Resources
  • Mr. Micah J. Mitchell (Age 48)
    Chief Commercial Officer
    Comp: $317.39k

MYO Stock Analysis - Frequently Asked Questions

Should I buy or sell Myomo stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MYO shares.
View MYO analyst ratings
or view top-rated stocks.

What is Myomo's stock price target for 2024?

2 Wall Street analysts have issued twelve-month price targets for Myomo's stock. Their MYO share price targets range from $6.50 to $6.50. On average, they anticipate the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 98.8% from the stock's current price.
View analysts price targets for MYO
or view top-rated stocks among Wall Street analysts.

How have MYO shares performed in 2024?

Myomo's stock was trading at $4.74 at the beginning of the year. Since then, MYO shares have decreased by 31.0% and is now trading at $3.27.
View the best growth stocks for 2024 here
.

How were Myomo's earnings last quarter?

Myomo, Inc. (NYSEAMERICAN:MYO) issued its earnings results on Thursday, March, 7th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by $0.02. The business had revenue of $4.76 million for the quarter, compared to the consensus estimate of $4.70 million. Myomo had a negative net margin of 42.34% and a negative trailing twelve-month return on equity of 84.72%.

What guidance has Myomo issued on next quarter's earnings?

Myomo issued an update on its first quarter 2024 earnings guidance on Thursday, March, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.1 million-$4.3 million, compared to the consensus revenue estimate of $4.5 million.

What other stocks do shareholders of Myomo own?
Who are Myomo's major shareholders?

Myomo's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include AIGH Capital Management LLC (10.06%), Vanguard Group Inc. (4.59%), Vanguard Group Inc. (4.37%), Essex Investment Management Co. LLC (0.36%), Citadel Advisors LLC (0.25%) and Northern Trust Corp (0.20%). Insiders that own company stock include David A Henry, Harry Kovelman, Micah Mitchell, Milton Mayo Morris, Paul R Gudonis, Thomas Aloysius Jr Crowley and Thomas F Kirk.
View institutional ownership trends
.

How do I buy shares of Myomo?

Shares of MYO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:MYO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners